Elanco Animal Health (ELAN) Interest Expenses (2018 - 2026)
Elanco Animal Health (ELAN) posted Interest Expenses of $57.0 million for Q1 2026, down 28.75% sequentially from $80.0 million in Q4 2025, and up 42.5% YoY from $40.0 million in Q1 2025.
Elanco Animal Health (ELAN) Interest Expenses (2018 - 2026) Analysis & Trends
Elanco Animal Health has reported Interest Expenses for 9 years, with the latest figure at $57.0 million in Q1 2026.
- Quarterly Interest Expenses rose 42.5% year-over-year to $57.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $229.0 million (up 9.57% YoY) and the FY2025 annual result came in at $220.0 million, down 25.68% from the prior year.
- Interest Expenses declined to $57.0 million in Q1 2026 per ELAN's latest filing, from $80.0 million in the prior quarter.
- Over five years, Interest Expenses peaked at $169.0 million in Q4 2023 and troughed at $40.0 million in Q1 2025.
- A 5-year average of $72.5 million and a median of $68.0 million in 2022 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses jumped 94.25% in 2023, then plunged 72.78% in 2024.
- Over 5 years, Interest Expenses stood at $87.0 million in 2022, then surged by 94.25% to $169.0 million in 2023, then plunged by 72.78% to $46.0 million in 2024, then jumped by 73.91% to $80.0 million in 2025, then decreased by 28.75% to $57.0 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $57.0 million, $80.0 million, and $52.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | 25.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.00 Mn |
| Jun 30, 2026 | 59.00 Mn |
| Mar 31, 2026 | 57.00 Mn |
| Mar 31, 2026 | 57.00 Mn |
| Dec 31, 2025 | 80.00 Mn |
| Dec 31, 2025 | 80.00 Mn |
| Sep 30, 2025 | 52.00 Mn |
| Sep 30, 2025 | 52.00 Mn |
| Jun 30, 2025 | 83.00 Mn |
| Jun 30, 2025 | 83.00 Mn |
| Mar 31, 2025 | 40.00 Mn |
| Mar 31, 2025 | 40.00 Mn |
| Dec 31, 2024 | 46.00 Mn |
| Dec 31, 2024 | 46.00 Mn |
| Sep 30, 2024 | 58.00 Mn |
| Sep 30, 2024 | 58.00 Mn |
| Jun 30, 2024 | 65.00 Mn |
| Jun 30, 2024 | 65.00 Mn |
| Mar 31, 2024 | 66.00 Mn |
| Mar 31, 2024 | 66.00 Mn |